Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 14 | -907K | 100% | $57.71 | -$52.3M |
Net | -14 | -907K | -100% | -$52.3M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Morningside Venture Investments Ltd | 10%+ Owner | $816M | Nov 18, 2021 | ||
Cedric Francois | Chief Executive Officer, Director | $145M | -$18.1M | -11.1% | Mar 1, 2024 |
Pascal Deschatelets | Chief Scientific Officer | $51.1M | -$12.9M | -20.2% | May 20, 2024 |
Alec Machiels | Director | $50.2M | -$177K | -0.35% | Jan 1, 2024 |
Timothy Sullivan | Chief Financial Officer | $19.1M | -$1.92M | -9.16% | Apr 18, 2024 |
Adam Townsend | Chief Commercial Officer | $8.55M | -$7.2M | -45.7% | Feb 12, 2024 |
Lukas Scheibler | Chief Research Officer | $6.96M | -$600K | -7.93% | Dec 1, 2023 |
Caroline Baumal | Chief Medical Officer | $6.17M | -$165K | -2.61% | Jan 16, 2024 |
Federico Grossi | Chief Medical Officer | $6.04M | Jan 5, 2023 | ||
Jeffrey Eisele | Chief Development Officer | $5.63M | -$1.04M | -15.7% | Jan 29, 2024 |
Nur Nicholson | Chief Technical Officer | $5.15M | -$1.89M | -26.9% | Mar 13, 2024 |
Karen Lewis | Chief People Officer | $4.68M | -$791K | -14.5% | Jan 29, 2024 |
Sinclair Dunlop | Director | $4.31M | -$5.61M | -56.6% | Jun 28, 2024 |
David Watson | General Counsel | $2.74M | -$890K | -24.5% | Mar 6, 2024 |
James Chopas | VP/Chief Accounting Officer | $2.32M | -$165K | -6.65% | Sep 3, 2024 |
Mark DeLong | Chief Business & Strat Officer | $1.82M | -$833K | -31.4% | Aug 12, 2024 |
Victoria Brown | Program Team Lead | $1.5M | Jan 20, 2023 | ||
Paul R. Fonteyne | Director | $1.43M | Jan 1, 2024 | ||
Gerald Chan | Director | $1.11M | Jan 1, 2024 | ||
Stephanie O'Brien | Director | $1.11M | Jan 1, 2024 | ||
Nicole Perry | Vice President - Accounting | $717K | Aug 2, 2021 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|